Related Experiment Videos
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
1Department of Biology, Beckman Research Institute, City of Hope Medical Center, Duarte, California, USA.
Abstract:
Allelic loss at the short arm of chromosome 3 is one of the most common and earliest events in the pathogenesis of lung cancer, and is observed in more than 90% of small-cell lung cancers (SCLCs) and in 50-80% of non-small-cell lung cancers (NSCLCs). Frequent and early loss of heterozygosity and the presence of homozygous deletions suggested a critical role of the region 3p21.3 in tumorigenesis and a region of common homozygous deletion in 3p21.3 was narrowed to 120 kb (ref. 5). Several putative tumour-suppressor genes located at 3p21 have been characterized, but none of these genes appear to be altered in lung cancer. Here we describe the cloning and characterization of a human RAS effector homologue (RASSF1) located in the 120-kb region of minimal homozygous deletion. We identified three transcripts, A, B and C, derived from alternative splicing and promoter usage. The major transcripts A and C were expressed in all normal tissues. Transcript A was missing in all SCLC cell lines analysed and in several other cancer cell lines. Loss of expression was correlated with methylation of the CpG-island promoter sequence of RASSF1A. The promoter was highly methylated in 24 of 60 (40%) primary lung tumours, and 4 of 41 tumours analysed carried missense mutations. Re-expression of transcript A in lung carcinoma cells reduced colony formation, suppressed anchorage-independent growth and inhibited tumour formation in nude mice. These characteristics indicate a potential role for RASSF1A as a lung tumour suppressor gene.
Insights
Loss of the RASSF1A gene is common in lung cancer, particularly small-cell lung cancer. Restoring RASSF1A expression suppressed tumor growth, indicating its role as a lung tumor suppressor.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Allelic loss on chromosome 3p is a frequent early event in lung cancer pathogenesis.
- The 3p21.3 region is critical for tumorigenesis, with homozygous deletions identified in lung cancers.
Purpose of the Study:
- To clone and characterize a novel gene, RASSF1, within the critical 3p21.3 homozygous deletion region.
- To investigate the role of RASSF1A as a potential tumor suppressor gene in lung cancer.
Main Methods:
- Cloning and characterization of RASSF1 transcripts (A, B, C).
- Analysis of RASSF1A expression in normal tissues, small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) cell lines.
- Assessment of RASSF1A promoter methylation and mutation in primary lung tumors.
- Functional studies involving re-expression of RASSF1A in lung carcinoma cells.
Main Results:
- RASSF1, a RAS effector homologue, was identified in the minimal homozygous deletion region of 3p21.3.
- Major transcripts RASSF1A and RASSF1C were expressed in normal tissues, but RASSF1A was absent in SCLC cell lines.
- RASSF1A loss of expression correlated with promoter methylation (40% of primary lung tumors) and mutations (4 out of 41 tumors).
- Re-expression of RASSF1A suppressed colony formation, anchorage-independent growth, and tumor formation in vivo.
Conclusions:
- RASSF1A functions as a lung tumor suppressor gene.
- Epigenetic silencing (promoter methylation) and genetic alterations contribute to RASSF1A inactivation in lung cancer.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation